Table 1 Cost-effectiveness of standard ECP screening vs autonomous AI screening in pediatric patients with Type 1 and Type 2 diabetes

From: Cost-effectiveness of AI for pediatric diabetic eye exams from a health system perspective

Scenario

Number of pediatric endocrine sites across health system

Annual diabetes patient volume

Screening Strategy

Health system cost (USD $)

Cost difference of the AI and ECP strategies (Δ Cost)

Number of Patients Screened through each strategy

Difference in Effect (Δ Effect of AI and ECP strategies))

ICER (Δ Cost/ Δ Effect)

Small health system

1

100

Standard: ECP strategy

$8927

 

52

  

Alternative: AI strategy

$19,368

$10,441

95

43

242

Small health system

1

200

Standard: ECP strategy

$17,854

 

104

  

Alternative: AI strategy

$20,935

$3081

190

86

36

Medium- sized health system

1

400

Standard: ECP strategy

$35,707

 

208

  

Alternative: AI strategy

$24,070

–$11,637

380

172

-68

Medium- sized health system

1

600

Standard: ECP strategy

$53,561

 

311

  

Alternative: AI strategy

$27,205

–$26,356

570

259

-102

Medium- sized health system

2

400

Standard: ECP strategy

$35,707

 

208

  

Alternative: AI strategy

$41,870

$6163

380

172

36

Medium- sized health system

2

600

Standard: ECP strategy

$53,561

 

311

  

Alternative: AI strategy

$45,005

–$8556

570

259

-33

Large health system

3

1000

Standard: ECP strategy

$89,268

 

519

  

Alternative: AI strategy

$69,075

–$20,193

950

431

-47

Large health system

3

4000

Standard: ECP strategy

$357,072

 

2076

  

Alternative: AI strategy

$116,100

–$240,972

3800

1724

-140

Large health system

4

1000

Standard: ECP strategy

$89,268

 

519

  

Alternative: AI strategy

$86,875

-$2393

950

431

-6

Large health system

4

4000

Standard: ECP strategy

$357,072

 

2076

  

Alternative: AI strategy

$133,900

–$223,172

3800

1724

-129